{"url_path":"/sec/zura/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1855644/0001855644-26-000007-index.html","accession_number":"0001855644-26-000007","cik":"0001855644","ticker":"ZURA","issuer_name":"Zura Bio Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855644/0001855644-26-000007-index.html","primary_entity_key":"0001855644","primary_entity_name":"Zura Bio Ltd"},"word_count":85,"has_tables":true,"body_markdown":"Item 9.01.    Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit No.Description\n\n[99.1](zura-20260811xex991.htm)\n\n[Press Release dated](zura-20260811xex991.htm)[August 11](zura-20260811xex991.htm)[, 2026](zura-20260811xex991.htm)\n\n[99.2](corporatedeck_zurabiox11.htm)\n\n[Corporate Presentation, dated August 11, 2026](corporatedeck_zurabiox11.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nZURA BIO LIMITED\n\nDate: August 11, 2026By:/s/ Kim Davis\n\nKim Davis\n\nChief Operating Officer, Chief Legal Officer and Corporate Secretary"}